162 related articles for article (PubMed ID: 9048493)
1. Secretory response of cultured acinar cells of rat pancreas to cholecystokinin.
Kim H; Kim KH
Yonsei Med J; 1996 Dec; 37(6):405-11. PubMed ID: 9048493
[TBL] [Abstract][Full Text] [Related]
2. Selective activation by photodynamic action of cholecystokinin receptor in the freshly isolated rat pancreatic acini.
An YP; Xiao R; Cui H; Cui ZJ
Br J Pharmacol; 2003 Jun; 139(4):872-80. PubMed ID: 12813011
[TBL] [Abstract][Full Text] [Related]
3. Mecamylamine, a nicotinic receptor channel antagonist, affects amylase secretion by isolated pancreatic acinar cells.
Rayford PL; Chowdhury P
J Assoc Acad Minor Phys; 2001 Mar; 12(1-2):105-8. PubMed ID: 11851194
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini.
Tashiro M; Hirohata Y; Kihara Y; Akiyama T; Otsuki M
Pancreas; 1999 Mar; 18(2):156-64. PubMed ID: 10090413
[TBL] [Abstract][Full Text] [Related]
5. Characterization of interactions between CCK-33 and CCK receptors in isolated dispersed pancreatic acini.
Hosotani R; Chowdhury P; Doi R; Rayford PL
J Cell Physiol; 1992 Dec; 153(3):523-7. PubMed ID: 1280279
[TBL] [Abstract][Full Text] [Related]
6. A novel micromethod for pancreatic acinar secretion. Time course of CCK stimulation and its inhibition by L-364,718.
Adrian TE; Zucker KA; Bilchik AJ; Modlin IM
Int J Pancreatol; 1990 Jan; 6(1):61-9. PubMed ID: 1700032
[TBL] [Abstract][Full Text] [Related]
7. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT
Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137
[TBL] [Abstract][Full Text] [Related]
9. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
[TBL] [Abstract][Full Text] [Related]
10. Dose-response for inhibition by amylin of cholecystokinin-stimulated secretion of amylase and lipase in rats.
Young AA; Jodka C; Pittner R; Parkes D; Gedulin BR
Regul Pept; 2005 Aug; 130(1-2):19-26. PubMed ID: 15982756
[TBL] [Abstract][Full Text] [Related]
11. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic exocrine response to long-term high-fat diets in rats.
Lee KY; Ahn HC; Kim C; Kim SH; Kim DK; Park HS
JOP; 2006 Jul; 7(4):397-404. PubMed ID: 16832137
[TBL] [Abstract][Full Text] [Related]
13. A new CCK-B/gastrin receptor antagonist acts as an agonist on the rat pancreas.
Koop I; Eissele R; Richter S; Patberg H; Meyer F; Mössner J; Arnold R; Koop H
Int J Pancreatol; 1994 Jun; 15(3):215-22. PubMed ID: 7523549
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
Akiyama T; Tachibana I; Otsuki M
Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744
[TBL] [Abstract][Full Text] [Related]
15. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
[TBL] [Abstract][Full Text] [Related]
16. Effect of CCK-octapeptide and secretin on amylase secretion in isolated rat pancreatic acinar cells.
Lee PC
Digestion; 1979; 19(1):6-14. PubMed ID: 456770
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
18. Effect of cinnamtannin B-1 on cholecystokinin-8-evoked responses in mouse pancreatic acinar cells.
Rivera-Barreno R; del Castillo-Vaquero A; Salido GM; Gonzalez A
Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):980-8. PubMed ID: 20626416
[TBL] [Abstract][Full Text] [Related]
19. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
[TBL] [Abstract][Full Text] [Related]
20. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
